baber/WOPTO huggingface dataset:
Patent BR-PI1100958-B1 (BR)
Title: Válvula de ventilação
Inventor: Heiko Maisenhälder
IPC: F16K15/16
Filed: 2011-03-14
Abstract: válvula de ventilação. a presente invenção refere-se a uma válvula de ventilação tendo uma parte de fixação e um corpo de válvula que é provido com pelo menos uma fenda de ventilação. de modo que a válvula de ventilação seja produzida e montada de uma forma simples e econômica e, ainda, assegure uma ação de vedação confiável e requeira pouco espaço de montagem, na fenda de ventilação está atuando uma tração de fechamento que é causada por uma força gerada na válvula de ventilação após a montagem. durante a montagem da válvula de ventilação no respectivo aparelho, a força é obrigatoriamente gerada e, por sua vez, exerce sua tração de fechamento sobre a válvula de ventilação. as válvulas de ventilação são adequadas para a vedação de aparelhos, tais como um motor, um eixo ou alojamentos de transmissão.
Patent EA-002504-B1 (EA)
Title: Low voltage multipole circuit breaker with high electrodynamic resistance, whereof the pole shaft is arranged in the compartment housing the poles
Inventor: HERPIN LEAN-PHILIPPE
IPC: H01H3/30
Filed: 1999-06-07
Abstract: 1. A low-voltage circuit breaker of high electrodynamic strength with a case made of insulating material, comprising an operating mechanism linked to a pole shaft supported by bearings securely affixed to the case, a plurality of poles, each pole comprising at least one pair of separable contact parts, one at least of the contact parts of each pair, called the movable contact part, being mechanically linked to the pole shaft, the pole shaft, operating mechanism and movable contact part being able to move between an open position corresponding to separation of the contact parts of each pair and a closed position corresponding to contact between the contact parts of each pair, the case of the circuit breaker comprising a front compartment housing the operating mechanism and a rear compartment separated from the front compartment by an intermediate wall and subdivided into individual compartments by separating partitions, each individual compartment housing one of the poles of the circuit breaker, wherein the rotation axis of the pole shaft is located in the rear compartment. 2. The circuit breaker according to claim 1, wherein each of said separating partitions supports one of said bearings and the pole shaft passes through each partition at the level of one of said bearings. 3. The circuit breaker according to claim 2, wherein each of said separating partitions comprises a partition element molded with the intermediate wall, in an edge of which wall there is formed a semi-cylindrical sector forming a part of the corresponding bearing. 4. The circuit breaker according to claims 1 to 3, wherein the intermediate wall comprises a window for passage of a mechanical link part between the pole shaft and the operating mechanism. 5. The circuit breaker according to claims 1 to 4, wherein the external surface of the pole shaft is made of electrically insulating material. 6. The circuit breaker according to claims 1 to 5, comprising at least one connecting rod between the pole shaft and each movable contact part, this rod being linked to the pole shaft by a pivot in such a way that in a certain relative position of the shaft and of the rod, called the assembly position, the connecting rod can be freely moved in a direction parallel to the axis of the pivot, and once the connecting rod has been fitted and moved from its fitting position, a positive link is achieved preventing translational movement of the rod in a direction parallel to the axis of the pivot, the assembly position being such that in the operating state, the pole shaft and rod never take this position.
Patent EA-007534-B1 (EA)
Title: Stent device based on quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
Inventor: MYRES MICHAEL R
IPC: A61M25/10
Filed: 1999-11-23
Abstract: This invention is directed to a stent device including a polymer coating comprising quinoline/quinoxaline compounds of formula (I), which inhibit platelet-derived growth factor or p56tyrosine kinase activity, to use of a stent device for treating restenosis and to use compounds of formula (I) for manufacturing a stent device.
Patent EA-005255-B1 (EA)
Title: Method for treating syndrome of acute pulmonary injury at sepsis
Inventor: SPAS VLADIMIR VLADIMIROVICH
IPC: A61M1/36
Filed: 2002-12-24
Abstract: 1. A method for treating an acute pulmonary injury in sepsis, comprising partial blood transfusion from an organism, treating it with pulsed magnetic field and returning it back, characterized in that prior to the blood treatment with the magnetic field hemoperfusion of the transfused blood is performed using a biospecific antiproteinase sorbent and the blood is treated with low frequency pulsed magnetic field with impulse frequency 60-200 Hz during at least 30 minutes, the pulse amplitude is 100-120 mT. 2. The method according to claim 1, characterized in that the volume of treated blood per cycle is at least 3000 ml. 3. The method according to claim 1 or 2, characterized in that the rate of blood perfusion in the circuit is at least 100 ml/min. 4. The method according to any one of claims 1-3, characterized in that the magnetic treatment is performed once/day, totally 3-7 times.
Patent EA-006152-B1 (EA)
Title: Method for facilitating the transfer and packaging of foodstuffs
Inventor: SAVELA PEKKA
IPC: A21B3/13
Filed: 2003-12-22
Abstract: The invention relates to a method that can be used to transfer foodstuffs in a frozen form from the place of manufacture to the application or for further processing. According to the method, the foodstuff is fixed to a base, such as baking paper, which endures freezing and transferring, by means of a fixing agent composition not harmful for human consumption, the base with the foodstuff is frozen and, after freezing, the base with the foodstuff in the frozen state is transferred to be further processed. The fixing agent composition attaches the foodstuff to the base during freezing, but after baking, the foodstuff is easy to detach. The composition comprises a biopolymer and a softening agent.
Patent EA-005885-B1 (EA)
Title: Safety closure device for bottles and the like provided with a tamper optical indicator
Inventor: BATTEGAZZORE PIERO
IPC: B65D55/02
Filed: 2002-05-07
Abstract: The present invention relates to a safety closure device (1) for bottles (2) and the like, provided with a tamper optical indicator, characterised in that it contains at least one disk member (40) which is transversal with respect to a cap (4), where said disk member (40) exhibits on its upper surface (41) at least one projection (43) and coupling means (39, 50) on its lower surface (42). Breakable container means (19) containing substances capable of changing the conditions of the visible zone through a transparent portion (20, 21) of the cap (4) is provided between the projection (43) of the upper surface of the disk member (40). In particular, the coupling means (39; 50) determines a relative movement between he disk member (40) and the breakable container means (19) when a user unscrews the cap (4) so as to cause the penetration between the projection (43) and the container means.
Patent EA-007389-B1 (EA)
Title: Method for treating ulceroerosive diseases of oral micosa
Inventor: DEDOVA LYUDMILA NIKOLAEVNA
IPC: A61P1/02
Filed: 2005-01-31
Abstract: The present invention relates to medicine, in particular, to stomatology.The inventive aim provides a treatment time decrease, regeneration process speeding-up and broadening a range of medicaments for treating ulceroerosive-diseases of oral mucosa using a biene medicament, which has never been administered before for said purpose.The method is characterized in that for treating ulceroerosive-diseases of oral mucosa a complex of routine therapy comprises a method of biene liniment applying for 7-10 minutes twice a day for 5-6 days. The method reduces the treatment time.
Patent EA-010172-B1 (EA)
Title: Electro-chemical sensor
Inventor: JIANG LI
IPC: E21B47/10
Filed: 2004-12-22
Abstract: An electro-chemical sensor is described having two molecular redox systems sensitive to the same species and having an detector to detect relative shifts in the voltammograms of the two redox systems.
Patent EA-011439-B1 (EA)
Title: Fused pyrimidine derivatives and compositions thereof as cxcr3 receptor modulators, useful in prevention and treatment and of inflammatory and immunoregulatory disorders and diseases
Inventor: FU ZICE
IPC: A61K31/519
Filed: 2005-06-28
Abstract: Compounds are provided having the formula:wherein variables R, R, R, R, R, A, A, L, Q, X and subscript n as described herein. The subject compounds are useful for treatment of inflammatory and immune conditions and diseases. Compositions and methods of treatment using the subject compounds are also provided. For example, the subject methods are useful for treatment of inflammatory and immune disorders and disease such as multiple sclerosis, rheumatoid arthritis, psoriasis, and inflammatory bowel disease.
Patent EA-009267-B1 (EA)
Title: Sealing means for a closure, closure and process
Inventor: DRUITT RODNEY
IPC: B65D41/04
Filed: 2005-08-02
Abstract: The present invention is directed to a sealing means (2) for sealing of a neck (25) of a container, especially a container for carbonated beverages. The sealing means comprises a radially deformable outer sealing means (20) suitable to be engaged with an outer free surface (17) of a neck (25) of the container. The outer sealing means (20) comprises an annular base (22) which blends by a blend (34) into a vertical top surface (35) and at least one annular sealing ring (23) arranged at a free end of the annular base (22), protruding radially inwardly above the inner surface of the base (22) and forming in engaged position with the neck (25) a first contact area (30) with the outer free surface (17).
Patent EA-012097-B1 (EA)
Title: Device for hot-dip coating of a metal strip
Inventor: KIPPING MATTHIAS
IPC: C23C2/00
Filed: 2006-06-22
Abstract: The invention relates to a device for the hot-dip coating of a metal strip (1), more particularly of a steel band, in which the metal strip (1) is guided vertically through a container (3) containing the molten coating metal (2) and through an upstream guide channel (6), in the vicinity of which, on both sides of the metal strip (1), are arranged at least two inductors (8) for generating an electromagnetic field for holding the coating metal (2) in the container (3), a furnace chamber (9), which contains guide means and has a protective gas atmosphere, being located upstream of the guide channel (6). In order to ensure a good, durable seal between the guide channel (6) and the furnace chamber (9) under the established conditions, the invention proposes that a gas-tight, heat-resistant and flexible seal (13) be arranged between the furnace chamber (9) and the guide channel (6).
Patent EA-011906-B1 (EA)
Title: Carbon brush conductor with connection cable
Inventor: KAIN GOTTFRIED
IPC: H01R39/36
Filed: 2007-11-21
Abstract: The invention relates to a carbon brush conductor (1) with connecting cable (3) comprising single wires (4) and insulating jacket (5) preferably made of teflon, wherein the stripped end-section of the cable (3) is introduced into a blind hole (2) of the carbon brush conductor (1), by means of a contact closed up by stuffing. According to the invention the length of the stripped end-section of the cable (3) is dimensioned so that the insulating jacket of the cable (3) lies in the blind hole (2), wherein a ramming powder is located between the insulating jacket (5) and the inner wall of the blind hole (2). Resin admixed to the ramming powder or applied thereon forms a seal between the insulating jacket (5) and the inner wall of the blind hole (2).
Patent EA-012779-B1 (EA)
Title: Vessel having pressurized cogas source
Inventor: OBERHOFER KURT
IPC: B67D1/04
Filed: 2006-05-27
Abstract: The pressurized COgas source is an insert which can be attached with sealing in an orifice of the vessel. The insert has a high-pressure COcartridge (14), a pressure control valve for delivering COtherefrom and a rotary knob (24) accessible from the outside. The rotary knob (24) interacts with an axial pusher (40), actuation of which allows the high-pressure COcartridge (14) to be pierced by a piercing needle (34).
Patent EA-017696-B1 (EA)
Title: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
Inventor: LIU HONG
IPC: C07D207/40
Filed: 2007-12-12
Abstract: The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).
Patent EA-016737-B1 (EA)
Title: Safety element for protection of healthy eyes and therapy and prophylaxis device (embodiments)
Inventor: SANCHEZ RAMOS CELIA
IPC: A42B3/04
Filed: 2007-09-07
Abstract: The invention is a filtering, transparent device for preventing damage to healthy eyes and for the prophylaxis or therapy of pseudophakic eyes and/or eyes with macular and retinal neurodegeneration. It is characterized by being the result of applying a yellow filter at least to one transparent or translucent surface of the visor of a protective helmet, to protect the eyes from the short wavelengths of the visible spectrum (500 to 380 nm). The aforementioned element can be applied to the visors of helmets used in motorcycling, in outside sports, such as water sports or skiing, or in high-risk occupations, particularly metal welding. The invention avoids the difficulties and risks of existing ways of protecting healthy eyes or eyes subjected to cataract surgery, and improves the protection of eyes suffering retinal neurodegeneration, simply by applying a filter at least to one transparent or translucent surface of the visor of any protective helmet. The invention consists of combining at least one transparent or translucent surface of the visor of any protective helmet with a yellow filter which absorbs short wavelengths of light from 500 to 380 nm.
Patent EA-030035-B1 (EA)
Title: Use of s-ethylisothiouronium diethylphosphate for the manufacture of a medicament for treating a uterine hypercontractility disorder
Inventor: BARKAN REFAEL
IPC: A61K31/155
Filed: 2008-11-06
Abstract: The present invention relates to treating uterine hypercontractility disorders. In particular, the present invention relates to the use of S-ethylisothiouronium diethylphosphate for the manufacture of a medicament for treating a uterine hypercontractility disorder selected from the group consisting of abnormal uterine bleeding and dysmenorrhea.
Patent EA-019838-B1 (EA)
Title: COVALENT CONJUGATES OF α,α-DISUBSTITUTED GLYCINE ESTER AND MODULATOR OF ACTIVITY OF INTRACELLURAR ENZYME OR RECEPTOR
Inventor: DRUMMOND ALAN HASTINGS
IPC: A61K47/48
Filed: 2009-02-27
Abstract: Covalent conjugates of an α,α-disubstituted glycine ester and a modulator of the activity of a target intracellular enzyme or receptor, wherein the ester group of the conjugate is hydrolysable by one or more intracellular carboxylesterase enzymes to the corresponding acid and the α,α-disubstituted glycine ester is conjugated to the modulator at a position remote from the binding interface between the inhibitor and the target enzyme or receptor pass into cells and the active acid hydrolysis product accumulates within the cells.
Patent EA-019439-B1 (EA)
Title: Use of carboxamides on cultivated plants
Inventor: GEWEHR MARKUS
IPC: A01N37/22
Filed: 2009-10-21
Abstract: The present invention relates to a method of controlling pests and/or increasing the health of a plant as compared to a corresponding control plant by treating the cultivated plant, parts of a plant, seed, or their locus of growth with a carboxamide compound selected from the group consisting of boscalid, N-(3',4',5'-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide and bixafen.
Patent EA-022630-B1 (EA)
Title: An apparatus and a method for analysing the vibration of a machine having a rotating part
Inventor: HEDIN LARS-OLOV ELIS
IPC: G01M13/00
Filed: 2010-02-26
Abstract: An apparatus and a method for analysing the condition of a machine having a part rotatable with a speed of rotation, comprising inputs for receiving a vibration signal, the speed of rotation and operator control signals. An A/D converter, an enveloper, a decimator, an enhancer operating in the time domain to perform discrete autocorrelation and an analyzer for performing a condition monitoring function so as to analyse the condition of the machine.
Patent EA-019777-B1 (EA)
Title: Process for the preparation of ibodutant (men15596) and related intermediates
Inventor: BONACCORSI FABRIZIO
IPC: A61K38/05
Filed: 2010-05-11
Abstract: This invention relates to a novel process for synthesising the product ibodutant, consisting of a small number of high-yield steps involving reagents and solvents with low environmental impact, characterised by the coupling of two portions, compounds (3) and (4), one of which (3) is synthesised by coupling of 6-methyl-2-benzo[b]thiophenecarboxylic acid (1) with 1-amino-alpha-alpha-cyclopentan carboxylic acid and subsequent cyclization with oxazolone, while the other, compound (4), is obtained from suitable highly selective functionalisations of 4-aminomethylpiperidine (2).
Patent EA-021912-B1 (EA)
Title: Method for prophylactic and/or therapeutic treatment of fibromyalgia
Inventor: GREVE HARALD
IPC: A61P43/00
Filed: 2010-07-12
Abstract: The present invention relates to a method for the prophylactic and/or therapeutic treatment of fibromyalgia by using an antifibromyalgic agent and other pharmaceutical active agent to form a pharmaceutical combination, wherein the antifibromyalgic agent along with pharmaceutically acceptable additives comprises a quinine-based active agent as quinine or at least one salt thereof, and the other pharmaceutical active agent is analgesic or antidepressant, and administering of the quinine-based active agent is estimated in the initial daily dose from 100 to 1000 mg with further reducing it to the maintaining daily dose decreased by 20-80% relative to the initial daily dose, in each case based on quinine.
Patent EA-023217-B1 (EA)
Title: Stand for ultrasonic inspection of railway wheels
Inventor: OLIVER JOHN R
IPC: G01N29/04
Filed: 2012-07-18
Abstract: The invention describes a method and a device for providing information of ultrasonic measurements of a railway wheel using an ultrasonic test fixture. The railway wheel is supported by two drive rollers, each having an indentation engaging with the wheel for providing rotation thereof. A multiple-position transducer moves across the rotating wheel, collecting ultrasonic test data while a fixed transducer correlates a reference position on the wheel to the collected test data. To maintain the accuracy of the reference position to the collected test data, it is desirable to maintain the rotational stability of the wheel, minimizing any dynamic instability caused by dimensional tolerances in the wheel. To mitigate instabilities resulting from dimensional tolerances, the indentations of the drive rollers, which engage and drive the flange of the wheel, are variably spaced using a resilient member to maintain frictional contact between the wheel and the drive roller. This allows the indentation to accommodate the varying dimensional tolerances of the wheel flange, mitigating the possibility of dynamic instability resulting from departure of the wheel flange from the indentation.
Patent EA-028376-B1 (EA)
Title: Porcine circovirus type 2 (pcv2), immunogenic composition containing the same, test kit, and application thereof
Inventor: KUO TSUN-YUNG
IPC: G01N33/569
Filed: 2011-12-20
Abstract: The invention provides a novel porcine circovirus type 2 (PCV2) strain with a deposit number of CCTCC No.V201117. The invention also provides immunogenic compositions containing the novel PCV2 strain, a PCV2 test kit, and applications of the novel PCV2 strain.
Patent EA-026680-B1 (EA)
Title: Agent for treatment of dry eye characterized by combining p2yreceptor agonist with hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2yreceptor agonist and hyaluronic acid or salt thereof
Inventor: SHICHIJO YUKO
IPC: A61P27/02
Filed: 2011-09-09
Abstract: The present invention relates to an agent for treatment of dry eye which is an ophthalmic solution comprising a combination of a P,P-bis-(5'-uridyl)tetraphosphate or a salt thereof at a concentration of 1 to 5% (w/v) and hyaluronic acid or a salt thereof at a concentration of 0.05 to 0.5% (w/v). This agent can promote the secretion of tear remarkably and can improve corneal epithelial disorders remarkably, and is therefore expected to be a novel agent for treatment of dry eye.
Patent EA-029007-B1 (EA)
Title: Novel heteroarylamide derivatives having antiandrogenic properties
Inventor: RATILAINEN JARI
IPC: C07D487/04
Filed: 2013-01-11
Abstract: The invention relates to novel heteroarylamide derivatives having formula (I)and N-oxides, stereoisomers and pharmaceutically acceptable salts thereof, where R, R, R, R', R", z and X are as defined in the claims. The arylamide derivatives of formula (I) have antiandrogenic properties. The invention also relates to compounds of formula (I) for use as a medicament and to pharmaceutical compositions comprising them and to their preparation.
Patent EA-031851-B1 (EA)
Inventor: MEDOFF MARSHALL
IPC: B01J19/08
Filed: 2013-10-10
Abstract: Описаны способы и системы для переработки целлюлозных и лигноцеллюлозных материалов в пригодные для использования промежуточные соединения и продукты, такие как энергия и топливо. Например, описаны транспортировочные системы, такие как высокоэффективные вибрационные транспортеры, для обработки целлюлозных и лигноцеллюлозных материалов.
Patent EA-033539-B1 (EA)
Title: Method of promotion of reparative angiogenesis and regeneration of damaged connective tissue by means of gene therapy using orphan genes of vegf and fgf2 protein factors in veterinary medicine, and genetic construct for realizing such method
Inventor: RIZVANOV ALBERT ANATOLIEVICH
IPC: C12N15/85
Filed: 2016-06-14
Abstract: The invention relates to veterinary medicine, biochemistry and biotechnology comprising a method to stimulate reparative angiogenesis and regeneration of connective tissue damaged or affected by disease in veterinary, which consists in administering genetically engineered DNA structure into the body of a horse of other domestic farm animal, that carries genes cloned into it to encode expressions of orphan genes in terms of horse protein factors, namely endothelial vascular growth factor of isoform 164 (VEGF164) and fibroblasts 2 (FGF2); the method according to claim 1 is characterized by the fact that the genetically engineered DNA structure is produced in the form of a plasmid structure, the method according to claim 1 is characterized by the fact that the genetically engineered DNA structure is made in the form of a viral vector or viral particles, the method according to claim 1 is characterized by the fact that the genetically engineered DNA structure is made in the form of a two-cluster expression plasmid pBud, expressing antigenic factor (vascular endothelial growth factor VEGF164) and fibroblasts horse growth factor 2 (FGF2), the method according to claims 1-4 is characterized by the fact that in order to implement the method it is necessary to use pharmaceutical composition containing a genetic DNA construct in an effective amount and pharmaceutically acceptable excipients, as well as viruses, microorganisms or cells, genetic DNA construct SEQ ID NO: 1, which is characterized by the fact that in order to implement the method according to claim 1 it is necessary to use a two-cluster expression plasmid DNA-structure created on the basis of pBudCE4.1 vector that has cloned orphan codon optimized genes that encode the expression of the domestic horse (Equus ferus caballus) orphan protein factors, namely vascular endothelial growth factor of isoform 164 (VEGF164) and fibroblasts 2 (FGF2).